Search for: rheumatoid arthritis methotrexate autoimmune disease biomarker gene expression GWAS HLA genes non-HLA genes
| ID | PMID | Title | PublicationDate | abstract |
|---|---|---|---|---|
| 1275575 | Preliminary observations on an isolate from synvoial fluid of patients with rheumatoid art | 1976 Feb | A very slow-growing micro-organism has been isolated from the synovial fluid of patients suffering from rheumatoid arthritis. This organism exhibits some of the properties of a mycoplasma such as growth in the presence of penicillin, and the requirement of serum and yeast, but generally does not behave like any known species of this group. Colonies resemble some types of T-mycoplasma in morphology and size. Scanning electron microscopy showed that the size of the components of these colonies was exceedingly small. | |
| 6603263 | Circulating immune complexes in malignant diseases increased detection rate by simultaneou | 1983 | By using three different assay methods, circulating immune complexes have been detected in 85% of sera from patients with malignant melanoma, and in 77% of sera from patients with breast cancer. These methods were a C1q-binding assay, a double-antibody conglutinin-binding ELISA, and a polyethylene glycol 6000 precipitation technique followed by quantitative determination of immunoglobulins in the redissolved precipitate. Detection rates of circulating immune complexes using any one of these methods separately ranged from 33% to 56%, indicating the presence of different types of circulating immune complexes in cancer patients' sera. The combined use of the three methods mentioned resulted in an increased diagnostic sensitivity and a doubling of the predictive value. However, tests for circulating immune complexes cannot be considered as useful parameters for early diagnosis of cancer, since the comparatively low incidence of malignancies in the population at large, together with the presence of circulating immune complexes in other, nonmalignant, diseases of considerable prevalence, appears to preclude effective application of any nonspecific method for early diagnosis of cancer in general. | |
| 143941 | The primary plasmin inhibitor in rheumatoid synovial fluid. | 1977 Sep | In 20 consecutive rheumatoid arthritis patients, 14 women and 6 men, age 26--76, average 62 years, the concentration of the recently found "primary plasmin inhibitor" and phase proteins was estimated in plasma and synovial fluid. In 12 patients a complex between the inhibitor and plasmin could be demonstrated by crossed immunoelectrophoresis into immunoglobulins against the primary plasmin inhibitor and immunoglobulin against plasminogen. Only free inhibitor was found in corresponding plasma. All plasminogen present in synovial fluid could be activated to plasmin upon addition of urokinase (24 nM/1). In those patients where enzyme-inhibitor complex in synovial fluid was present, a higher concentration of phase proteins in synovial fluid was found, indicating an increased degree of inflammation despite identical scores in the Lansbury clinical index in the two groups. From these experiments it was concluded that the fibrinolytic capacity in rheumatoid synovial fluid is not decreased. It is suggested that the fibrin-like material in synovial tissue and upon the synovial membrane is a poor substrate for plasmin. | |
| 831361 | Rheumatoid pseudotumor of urinary bladder simulating carcinoma. | 1977 Jan | A forty-nine-year-old female with seropositive rheumatoid arthritis was seen with hematuria and a urinary bladder lesion which on cystoscopic examination simulated carcinoma. Microscopic evaluation after segmental resection of the lesion revealed that it was a rheumatoid nodule. Rheumatoid nodules are known to occur in many parts of the body, but an extensive search of the literature has failed to reveal any previous report of urinary bladder involvement. | |
| 6442634 | Detection of anti-interferon antibodies in systemic lupus erythematosus. | 1983 Apr | In this study, we show that sera from 2 of 13 patients with clinically active systemic lupus erythematosus (SLE) contained anti-interferon alpha (anti-IFN alpha) antibody. In contrast, anti-IFN alpha activity was not detected in sera from patients with clinically inactive SLE, rheumatoid arthritis (RA), Sjögren's syndrome, or in normal individuals. None of the sera exhibited anti-IFN gamma activity. These studies show that anti-IFN antibody, like IFN itself, is most frequently observed in patients with clinically active SLE. It is also possible that the presence of IFN-anti-IFN complexes may contribute, in part, to the pathogenesis of this disease. | |
| 6301745 | Formation of hydroxyl radicals from hydrogen peroxide and iron salts by superoxide- and as | 1983 Jun | 1. Superoxide and hydrogen peroxide are formed by activated phagocytes and react together in the presence of iron salts to form the hydroxyl radical, which attacks hyaluronic acid. Ascorbic acid also interacts with hydrogen peroxide and iron salts to form hydroxyl radical in a reaction independent of superoxide. Since iron salts, ascorbate and activated phagocytes are present in the rheumatoid joint, experiments were designed to see whether ascorbate-dependent or superoxide-dependent formation of hydroxyl radicals would be more important in vivo. 2. In the present study, addition of ascorbate to a superoxide-generating system at concentrations of 100 mumol/l provoked a superoxide-independent formation of hydroxyl radicals for a short period. Lower concentrations of ascorbate did not do this. It is therefore suggested that the superoxide-dependent reaction is probably more important. 3. It is further suggested that destruction of ascorbate by oxygen radicals formed by activated phagocytes accounts for the previously reported low concentrations of this compound in the serum and synovial fluid of rheumatoid patients. | |
| 7056279 | The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease. | 1982 | Pharmacokinetic data for diclofenac sodium has been well established in healthy volunteers, whereas in patients with rheumatoid arthritis very little information is available in the literature. A single oral dose of enteric-coated diclofenac sodium was given to 10 patients with active rheumatoid disease, adopting the same procedures used for a group of 10 healthy volunteers in whom pharmacokinetic data was already available. Plasma specimens were collected over a period of 8h following administration and concentrations of diclofenac determined by GLC. Resulting plasma concentration curves were similar to those obtained in the healthy subjects in that areas under curves and terminal half-lives were comparable. However, peak concentrations of diclofenac were significantly reduced in the rheumatoid patients. The lower peak concentrations were correlated with the lower serum albumin levels in the patients which are associated with active rheumatoid disease. | |
| 99092 | Polymyositis in Chagas's disease. | 1978 Jun | Polymyositis marked the clinical onset of Chagas's disease in a patient with rheumatoid arthritis. This is unusual, although clinically unimportant muscle involvement in trypanosomiasis has been described. The plasma cell infiltrate and vascular deposition of IgM and C3 suggest that the humoral immune system may play a role in the pathogenesis of chagasic polymyositis. It is not known whether the rheumatoid diseases predisposed to the polymyositis. | |
| 6861410 | Supramalleolar osteotomy in the management of the rheumatoid hindfoot. | 1983 Jul | Supracondylar osteotomy is an alternative to other procedures for realignment of the rheumatoid hindfoot. Of 64 hindfoot operations performed since 1964, 12 were supracondylar osteotomies. The specific indication for this procedure was an ankylosed rheumatoid foot with equinovarus deformity and limited range of tarsal motion. Conventional triple arthrodesis in such circumstances creates a rigid foot, further compromising an already damaged ankle. Of the nine feet available for evaluation one to ten years after operation, seven were relieved of pain and two had anterior metatarsalgia from recurrence of equinus deformity. Correction of varus deformity was maintained in all. Ankle motion diminished from a mean of 17 degrees before operation to 7 degrees when reviewed. Five of the eight ankles had bony fusion. Mean rotatory tarsal motion was improved in two and diminished in seven; mean rotation remained constant, at approximately 13 degrees. Whereas ankle joint motion fared badly under the combined onslaught of disease and osteotomy, the preservation of tarsal motion, correction of deformity, and relief of pain make supramalleolar osteotomy a worthwhile alternative procedure under the specific circumstances cited. | |
| 6344809 | Immunoelectron microscopic demonstration of fibronectin in rheumatoid pannus and at the ca | 1983 Jun | The presence of fibronectin (Fn) in rheumatoid pannus was investigated by an immunoelectron microscopic method using horseradish peroxidase-conjugated antibody to stain Fn. Large amounts of Fn were demonstrated in the interstitial collagenous tissue of invasive rheumatoid pannus. Fn was also observed on the surface of both fibroblast-like and macrophage-like pannus cells, suggesting that it was secreted by these cells and that the secreted Fn might facilitate the spreading of the pannus cells over the cartilage matrix. However, decreased amounts of Fn were observed in areas of contact between pannus cells and the cartilage matrix. The reduction in the amount of Fn demonstrable at the cartilage-pannus junction may be a consequence either of proteolysis of Fn by enzymes secreted at the junction, inhibition of Fn synthesis in cells in contact with cartilage matrix, or transfer of Fn from the pannus cell surface to collagen of the cartilage matrix. | |
| 7003142 | Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus. | 1980 Sep | Immune deposits in the choroid of patients with systemic lupus erythematosus (SLE) are thought to relate to the pathogenesis of central nervous system (CNS) SLE. Using an immunoperoxidase technique, we found the presence of immunoglobulin heavy and light chains in the choroid stroma and/or in the ependymal cells in all of 7 patients with SLE, 2 of 4 with rheumatoid arthritis, but not in 3 subjects without autoimmune disease. The occurrence, pattern or intensity of the immunoglobulin deposits did not distinguish the patients with or without clinical neuropsychiatric manifestations. Thus, the presence of immune deposits in the choroid plexus is not specific for CNS involvement in SLE. | |
| 377476 | A double-blind study of erbium169 synoviorthesis in rheumatoid digital joints. Results aft | 1979 | A double-blind study was made on the effectivenss of erbium169 synoviorthesis in the digital joints of 7 patients with erosive, seropositive rheumatoid arthritis. The study involved 70 joints observed over a 12-month period: 20 pairs of metacarpophalangeal joints (MCP) and 15 pairs of proximal interphalangeal joints (PIP) were injected with erbium169 in one joint and saline in the other one. All joints had radiological lesions corresponding to State I and II of the Steinbroker classification. Six months after synoviorthesis, good and excellent results were observed in 71% of the articulations treated with erbium169 and in only 40% of those injected with saline (placebo) (p less than 0.01). Good and excellent results were noted in 79% of the joints treated with the isotope after one year, compared with only 50% injected with the placebo (p less than 0.05). The beneficial effect of erbium169 synoviorthesis on the pain and inflammatory phenomena of rheumatoid digital joints is therefore proven. Occasionally the isotope causes a slight decrease in the range of movement of the treated joint. | |
| 493892 | Synovial fluid and serum hydroxyproline fractions in rheumatoid arthritis. | 1979 | In rheumatoid arthritis (RA) the synovial fluid lymphocyte count closely parallels the synovial fluid dialysable hydroxyproline, a marker of collagen resorption. This observation stresses the primordial role of lymphocytes in RA joint injury. The actual and eventually potential destruction of any single joint, as expressed by synovial fluid dialysable hydroxyproline levels, seems to reflect the general picture of disease activity as evaluated by the number of active joints (joint count), ESR and rheumatoid factor titres (latex fixation). Although urinary hydroxyproline levels are generally within the normal range in RA, they can be used as index of articular tissue destruction and as a parameter of overall disease activity when groups of patients are studied longitudinally in detail. The present study sheds no further light on the significance of synovial fluid and blood non-dialysable hydroxyproline levels. | |
| 7029650 | A therapeutic trial of 15 (R)-15-methyl prostaglandin E2 in rheumatoid arthritis patients | 1981 | Thirteen patients who had rheumatoid arthritis and gastroduodenal lesion (erosions, ulcers) received 200 micrograms/d of 15(R)-15-methyl prostaglandin E2 (MPGE2) for one month in a controlled, randomized, double-blind crossover study. The patients continued their usual arthritis medications. Serial assessments were made with endoscopy and multiple antral biopsies. Seven patients improved on MPGE2 and 3 improved on placebo. Two patients worsened on MPGE2 compared with 3 on placebo. No dramatic benefit was observed after one month of therapy with MPGE2, although a moderate benefit could have been missed in a small study of this type. Our experience with this study suggests that future studies in rheumatoid arthritis should first establish the natural history of lesions in a given group of patients, that a cross-over design may actually hamper interpretation and that therapy should be more prolonged. | |
| 1225486 | Presence of antibodies specific to cartilage-type collagen in rheumatoid synovial tissue. | 1975 Dec | Synovial membranes of rheumatoid arthritis patients were examined by fluorescence microscopy for the presence of cells producing different classes of immunoglobulins and for the incidence of antibodies to human collagens. IgG and IgM immunoglobulins were detected while IgA, IgD and IgE were absent. When consecutive tissue sections were incubated with tetramethylrhodamine isothiocyanate-labelled collagen preparations, prominent cellular and extra-cellular staining was observed only with cartilage-derived Type II collagen. | |
| 1227274 | A contribution to the synovial fluid immunopathology in rheumatoid arthritis and other art | 1975 Jul | The role of the autoimmune or autoallergic process in Progressive Chronic Polyarthritis, has been the subject of a great deal of study in the last four decades. In this work, using the synovial fluid of 312 patients suffering Chronic Progressive Polyarthritis and other arthropaties, the immunopathologic aspects of these diseases are studies. The following techniques had been used: 1. Total protein determination 2. Animal immunization. 3. Gel diffusion. 4. Immunoelectrophoresis. 5. Cellogel electrophoresis. 6. Radial immunodiffusion. 7. Absorption. After a systematic discussion of each of the results obtained (comparing these findings with those of other authors) we have arrived to the following conclusions. 1. The great importance of the immunoglobulins' role in the immunization process and their relation with high total protein titres, especially in PCP. 2. The importance of the IgA role in Rheumatoid Arthritis and in Acute Lymphatic Leukemia, behaving in the former as a Rheumatoid Factor with autoantibody nature. 3. An antigenic community between plasma and synovial proteins, and protein fractions. 4. The existence o af synovial "self" protein could not be demonstrated "in vivo". | |
| 276349 | Experience with the Melbourne knee prosthesis, based on the first 35 operations over a thr | 1978 Feb | The Melbourne knee prosthesis is an improved hinge prosthesis. Its component parts are constructed of a chrome cobalt alloy and ultrahigh molecular weight polyethylene. The hinge has a range of flexion of 120 degrees, and while flexed, can rotate 15 degrees in either direction. Over the past three years a total of 45 prostheses have been inserted in patients with chronic degenerative arthritis of the knee joints. This survey covers the first 35 operations. The most gratifying result has been a dramatic relief of pain in 87.5% of patients. There have been few complications, and no prosthesis has had to be removed. There have been no mechanical failures of the prosthesis itself. | |
| 6418086 | Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorder | 1983 Dec | Moderate titres of antiviral activity were demonstrated in 48-58% of sera obtained from patients suffering from seropositive and seronegative rheumatoid arthritis (RA), psoriatic arthritis, Reiter's syndrome, ankylosing spondylitis, and juvenile rheumatoid arthritis. Sera from blood donors and from patients with various noninflammatory diseases were positive in 16% of cases. The activity was species-specific, mediated by the homologous cells, and destroyed by treatment with trypsin and exposure to pH 2. Antibodies against human IFN-alpha did not neutralise the activity. These characteristics are compatible with those of IFN-gamma or immune interferon. Neither the presence nor the titre of IFN was correlated with disease activity defined by concentration of C-reactive protein, C3 concentration, and erythrocyte sedimentation rate. IFN-gamma was present in 4 of 10 synovial fluids from patients with RA. The titre in one of these was higher than in the corresponding serum, indicating local production in the rheumatoid joint. | |
| 241174 | [Long-term toxicity of benorylate]. | 1975 Jul | A long term study was carried out to determine the possible toxic effects of therapeutic doses of a suspension of benorilate on bone marrow, liver and kidneys in 33 patients with rheumatoid arthritis. 14 were male and 19 femal patients. 11 of the male and 14 of the female patients presented a positive rheumatoid factor. The duration of the treatment was first limited to 6 months. In 20 of the 33 patients duration of treatment was extended to 7 and 91/2 months. Three patients interrupted treatment after respectively 2, 3 and 5 months. Benorilate was given in a daily dosage varying from 6-8-12 g (as a suspension containing 40% benorilate). The following parameters were used to determine the effect of the drug on bone marrow: Hemoglobin, erythrocyte count, leucocyte count, thrombocyte count. Tests were done at regular intervals to determine a possible toxic effect on the kidney: urea nitrogen, uric acid, creatinine and urineanalysis were performed at regular intervals. To determine any possible hepatic toxicity, SGOT, SGPT, alkaline phosphatase and prothrombin time were done at regular intervals. On the basis of the laboratory results, no toxicity could be demonstrated in bone marrow, liver and kidneys when benorilate was given in therapeutic doses for the treatment of rheumatoid arthritis. Rare temporary abnormal laboratory values are not statistically significant and can be considered part of systemic involvement secondary to rheumatoid arthritis. The combination of the two active substances of benorilate decreases to a minimum on the one hand the above mentioned side effects and on the other potentiates the therapeutic and especially the analgetic effect. After resorption, the preparation is hydrolized in the plasma to acetylic salicylic acid and paracetamol. The hydrolysis takes place in the gastrointestinal tract which probably explains why the drug is so well tolerated. | |
| 6141634 | [Enzymatic evaluation of blood donors]. | 1983 Nov | Enzymatic, immunologic and hematologic dosages were performed in a group of blood donors. A significant part of this population showed anomalies in the enzymes, either isolated or associated and of variable importance. A systematic serological study of viral hepatitis A (VHA) and viral hepatitis B (VHB) was performed among these donors with biochemical anomalies. A more general biological study (immunology and hematology) completes this work. |